Skip to main content
TipRanks
Go Ultimate75% OFF

Renalytix (RENX) Share Price & Analysis

22 Followers

RENX Stock Chart & Stats

GBX 5.40GBX 0.00(0.00%)
At close: 4:30 PM GMT
4 p5 p6 pAug 17Aug 28Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
GBX 5.28 - GBX 5.60
52-Week Range
GBX 1.60 - GBX 7.50
Previous Close
GBX 5.40
Volume
N/A
Average Volume (3M)
803.85K
Market Cap
GBP 36.20M
Enterprise Value
GBP 13.29M
Total Cash (Recent Filing)
GBP 6.20M
Total Debt (Recent Filing)
GBP 5.80M
Price to Earnings (P/E)
―
Beta
-0.54
Next Earnings
Dec 08, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

The sharp FY2026 revenue increase indicates stronger commercial traction for Renalytix’s kidney-risk diagnostics and expands the base from which operating leverage could develop. Continued adoption would improve the company’s ability to spread substantial fixed costs across a larger revenue stream.

Improving Cash Burn

The substantial reduction in operating cash burn shows progress toward more efficient operations and lowers the pace at which external financing is consumed. If maintained alongside growth, this improvement could extend funding runway and support a more durable path toward self-sustaining operations.

Lower Debt

Debt reduction improves the company’s financial profile by lowering fixed repayment obligations and potentially reducing financing pressure. Although equity remains negative, a smaller debt burden gives management greater flexibility to direct future funding toward commercialization, product development, and operating needs.

Bears Say

Negative Equity

Persistent negative equity signals a weakened capital base and limits financial flexibility, making Renalytix more dependent on continued external funding. This can constrain investment choices and leave the company less able to absorb setbacks while it works to scale its diagnostics business.

Persistent Negative Free Cash Flow

Ongoing negative free cash flow means the business is not yet funding its operations internally, despite the recent improvement in cash burn. Continued reliance on financing can dilute existing ownership or increase financial pressure, particularly if commercialization takes longer than expected.

Deep Unprofitability

The extreme gap between gross profit and operating costs shows that revenue remains far below the scale needed to support the current expense base. Even with recent growth and narrower losses, sustained operating deficits remain a major obstacle to durable profitability and cash generation.

Renalytix News

RENX FAQ

What was Renalytix’s price range in the past 12 months?
Renalytix lowest share price was 1.60 p and its highest was 7.50 p in the past 12 months.
What is Renalytix’s market cap?
Renalytix’s market cap is £36.20M.
When is Renalytix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Renalytix’s earnings last quarter?
Renalytix released its earnings results on Oct 28, 2026. The company reported -0.01 p earnings per share for the quarter.
Is Renalytix overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Renalytix pay dividends?
Renalytix does not currently pay dividends.
What is Renalytix’s EPS estimate?
Renalytix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Renalytix have?
Renalytix has 670,459,350 shares outstanding.
What happened to Renalytix’s price movement after its last earnings report?
Renalytix reported an EPS of -0.01 p in its last earnings report. Following the earnings report the stock price went down -5.882%.
Which hedge fund is a major shareholder of Renalytix?
Currently, no hedge funds are holding shares in GB:RENX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology